Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/yb-1-protein-in-breast-cancer-scientific-and-personal-meetings-with-i1c0wQVyZ1
References (75)
-
(2007)
Examining a role of YB 1 protein in breast cancer drug -
T. Sørlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M. Eisen, M. Rijn, S. Jeffrey, T. Thorsen, H. Quist, J. Matese, P. Brown, D. Botstein, P. Lønning, A. Børresen-Dale (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 98
-
A. V. Vayman, G. P. Gens, T. P. Stromskaya, E. Yu. Rybalkina, A. V. Sorokin (2007)
Examining a role of YB-1 protein in breast cancer drug resistanceMol. Med., 1
-
K. Imada, M. Shiota, Kenichi Kohashi, K. Kuroiwa, Yoohyun Song, Masaaki Sugimoto, S. Naito, Y. Oda (2013)
Mutual Regulation between Raf/MEK/ERK Signaling and Y-Box–Binding Protein-1 Promotes Prostate Cancer ProgressionClinical Cancer Research, 19
-
Y. Basaki, F. Hosoi, Yoshinao Oda, Abbas Fotovati, Y. Maruyama, Shinji Oie, M. Ono, H. Izumi, K. Kohno, K. Sakai, Tatsu Shimoyama, Kazuto Nishio, M. Kuwano (2007)
Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cellsOncogene, 26
-
C. Homer, D. Knight, L. Hananeia, P. Sheard, J. Risk, A. Lasham, J. Royds, A. Braithwaite (2005)
Y-box factor YB1 controls p53 apoptotic functionOncogene, 24
-
M. Kuwano, Y. Oda, H. Izumi, Song‐Ju Yang, T. Uchiumi, Y. Iwamoto, M. Toi, T. Fujii, H. Yamana, H. Kinoshita, T. Kamura, M. Tsuneyoshi, K. Yasumoto, K. Kohno (2004)
The role of nuclear Y-box binding protein 1 as a global marker in drug resistance.Molecular cancer therapeutics, 3 11
-
S. Swamynathan, Balwantkumar Varma, K. Weber, R. Guntaka (2002)
Targeted disruption of one allele of the Y-box protein gene, Chk-YB-1b, in DT40 cells results in major defects in cell cycle.Biochemical and biophysical research communications, 296 2
-
A. Stavrovskaya, T. Stromskaya, E. Rybalkina, N. Moiseeva, A. Vaiman, S. Guryanov, L. Ovchinnikov, G. Guens (2012)
YB-1 Protein and Multidrug Resistance of Tumor CellsCurrent Signal Transduction Therapy, 7
-
D. Faury, A. Nantel, S. Dunn, M. Guiot, T. Haque, P. Hauser, M. Garami, L. Bognár, Z. Hanzély, P. Liberski, E. López-Aguilar, E. Valera, L. Tone, A. Carret, R. Maestro, M. Gleave, J. Montes, T. Pietsch, S. Albrecht, N. Jabado (2007)
Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 10
-
(2013)
Protein YB 1 and predicting the course of breast cancer , Voprosy Onkol -
E. Dahl, A. En-Nia, F. Wiesmann, Renate Krings, S. Djudjaj, E. Breuer, T. Fuchs, P. Wild, A. Hartmann, S. Dunn, P. Mertens (2009)
Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancerBMC Cancer, 9
-
A. Lasham, Stephanie Moloney, T. Hale, C. Homer, You‐Fang Zhang, J. Murison, A. Braithwaite, James Watson (2003)
The Y-box-binding Protein, YB1, Is a Potential Negative Regulator of the p53 Tumor Suppressor*Journal of Biological Chemistry, 278
-
Akram Alkrekchi, Wei Wang, Priyanka Rana, V. Markovic, K. Sossey-Alaoui (2021)
Levels A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance.Cellular signalling
-
Adele Woolley, Michael Algie, W. Samuel, Rhodri Harfoot, A. Wiles, N. Hung, P. Tan, P. Hains, Valentina Valova, L. Huschtscha, J. Royds, David Perez, H. Yoon, Scott Cohen, P. Robinson, B. Bay, A. Lasham, A. Braithwaite (2011)
Prognostic Association of YB-1 Expression in Breast Cancers: A Matter of AntibodyPLoS ONE, 6
-
G. P. Gens, N. I. Moiseeva, E. Yu. Rybalkina, T. P. Stromskaya, A. V. Vayman (2010)
Intracellular protein YB-1 location and chemotherapy of breast cancerRoss. Bioter. Zhurn., 4
-
Wei-Wei Zhang, Huifang Huang, Qing-wei Li, Fei Ma (2006)
[Functions of Y-box binding protein and its role in tumorigenicity].Yi chuan = Hereditas, 28 9
-
M. Chatterjee, C. Rancsó, T. Stühmer, N. Eckstein, M. Andrulis, C. Gerecke, H. Lorentz, H. Royer, R. Bargou (2005)
The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma.Blood, 111 7
-
Yoshinao Oda, Akio Sakamoto, Norio Shinohara, T. Ohga, Takeshi Uchiumi, K. Kohno, Masazumi Tsuneyoshi, M. Kuwano, Yukihide Iwamoto (1998)
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.Clinical cancer research : an official journal of the American Association for Cancer Research, 4 9
-
T. Sinnberg, Birgit Sauer, P. Holm, B. Spangler, S. Kuphal, A. Bosserhoff, B. Schittek (2012)
MAPK and PI3K/AKT mediated YB‐1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loopExperimental Dermatology, 21
-
H. Saji, M. Toi, S. Saji, M. Koike, K. Kohno, M. Kuwano (2003)
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma.Cancer letters, 190 2
-
Mayu Takahashi, S. Shimajiri, H. Izumi, Gen Hirano, E. Kashiwagi, Yoshihiro Yasuniwa, Ying Wu, B. Han, Masaki Akiyama, S. Nishizawa, Y. Sasaguri, K. Kohno (2010)
Y‐box binding protein‐1 is a novel molecular target for tumor vesselsCancer Science, 101
-
C. Kosnopfel, T. Sinnberg, Birgit Sauer, H. Niessner, Alina Muenchow, B. Fehrenbacher, M. Schaller, P. Mertens, C. Garbe, B. Thakur, B. Schittek (2020)
Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and InvasionCancers, 12
-
G. Guens, N. Moiseeva, O. Ovsii, E. Rybalkina, A. tavrovskaya (2014)
Marker-Adjusted Personalized Chemotherapy of Breast Cancer, 2
-
Jingxiang Huang, P. Tan, K. Li, Ken Matsumoto, M. Tsujimoto, B. Bay (2005)
Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer.International journal of oncology, 26 3
-
B. Schittek, K. Psenner, Birgit Sauer, F. Meier, T. Iftner, C. Garbe (2007)
The increased expression of Y box‐binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistanceInternational Journal of Cancer, 120
-
C. Carter, Carol Allen, D. Henson (1989)
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 63
-
G. P. Gens, N. I. Moiseeva, E. Yu. Rybalkina, T. P. Stromskaya, A. V. Vayman (2013)
Protein YB-1 and predicting the course of breast cancerVoprosy Onkol., 59
-
G. P. Gens, A. A. Stavrovskaya (2010)
Protein YB-1 as a prognostic factor in breast cancerVestnik RONTs im. N. N. Blokhina RAMN, 21
-
T. Kamura, H. Yahata, S. Amada, S. Ogawa, Takanori Sonoda, H. Kobayashi, Masamune Mitsumoto, K. Kohno, M. Kuwano, H. Nakano (1999)
Is nuclear expression of Y box‐binding protein‐1 a new prognostic factor in ovarian serous adenocarcinoma?Cancer, 85
-
(2010)
Determining quantity of YB 1 gene mRNA in breast cancer tissues for prognosing disease course -
V. Evdokimova, P. Ruzanov, M. Anglesio, A. Sorokin, L. Ovchinnikov, J. Buckley, T. Triche, N. Sonenberg, Poul Sorensen (2006)
Akt-Mediated YB-1 Phosphorylation Activates Translation of Silent mRNA SpeciesMolecular and Cellular Biology, 26
-
A. Lasham, W. Samuel, Helen Cao, Rachna Patel, R. Mehta, J. Stern, G. Reid, Adele Woolley, L. Miller, M. Black, A. Shelling, C. Print, A. Braithwaite (2012)
YB-1, the E2F pathway, and regulation of tumor cell growth.Journal of the National Cancer Institute, 104 2
-
D. Hanahan, R. A. Weinberg (2000)
The hallmarks of cancerCell, 100
-
Ryan Huschka, A. Barhoumi, Qing Liu, J. Roth, L. Ji, N. Halas (2012)
Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA.ACS nano, 6 9
-
Tony Gutschner, S. Diederichs (2012)
The hallmarks of cancerRNA Biology, 9
-
I. Berquin, B. Pang, Michele Dziubinski, Latanya Scott, Yong Chen, G. Nolan, S. Ethier (2005)
Y-box-binding protein 1 confers EGF independence to human mammary epithelial cellsOncogene, 24
-
K. Kohno, H. Izumi, T. Uchiumi, Megumi Ashizuka, M. Kuwano (2003)
The pleiotropic functions of the Y-box-binding protein, YB-1.BioEssays : news and reviews in molecular, cellular and developmental biology, 25 7
-
C. Gessner, C. Woischwill, A. Schumacher, U. Liebers, H. Kuhn, P. Stiehl, K. Jürchott, H. Royer, C. Witt, G. Wolff (2004)
Nuclear YB‐1 expression as a negative prognostic marker in nonsmall cell lung cancerEuropean Respiratory Journal, 23
-
A. Carrière, Y. Romeo, Hugo Acosta-Jaquez, J. Moreau, É. Bonneil, P. Thibault, D. Fingar, Philippe Roux (2010)
ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)*The Journal of Biological Chemistry, 286
-
Sumin Kang, Jing Chen (2011)
Targeting RSK2 in human malignanciesExpert Opinion on Therapeutic Targets, 15
-
Jennifer Law, Yvonne Li, Karen To, Michelle Wang, A. Astanehe, K. Lambie, Jaspreet Dhillon, Steven Jones, M. Gleave, C. Eaves, S. Dunn (2010)
Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell ViabilityPLoS ONE, 5
-
Tomoyuki Fujita, Ken-ichi Ito, H. Izumi, M. Kimura, M. Sano, H. Nakagomi, K. Maeno, Y. Hama, K. Shingū, S. Tsuchiya, K. Kohno, M. Fujimori (2005)
Increased Nuclear Localization of Transcription Factor Y-Box Binding Protein 1 Accompanied by Up-Regulation of P-glycoprotein in Breast Cancer Pretreated with PaclitaxelClinical Cancer Research, 11
-
T. Yoshimatsu, H. Uramoto, T. Oyama, Yasunori Yashima, C. Gu, M. Morita, K. Sugio, K. Kohno, K. Yasumoto (2005)
Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.Anticancer research, 25 5
-
P. Gimenez-Bonafe, M. Fedoruk, Tanis Whitmore, M. Akbari, J. Ralph, S. Ettinger, M. Gleave, C. Nelson (2004)
YB‐1 is upregulated during prostate cancer tumor progression and increases P‐glycoprotein activityThe Prostate, 59
-
B. Sutherland, J. Kucab, Joyce Wu, Cathy Lee, Maggie Cheang, E. Yorida, D. Turbin, S. Dedhar, Colleen Nelson, M. Pollak, H. Grimes, K. Miller, S. Badve, D. Huntsman, C. Blakegilks, Min Chen, C. Pallen, S. Dunn (2005)
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cellsOncogene, 24
-
Valentina Evdokimova, C. Tognon, Tony Ng, P. Ruzanov, N. Melnyk, D. Fink, A. Sorokin, L. Ovchinnikov, E. Davicioni, T. Triche, Poul Sorensen (2009)
Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition.Cancer cell, 15 5
-
Y. Romeo, Xiaocui Zhang, Philippe Roux (2012)
Regulation and function of the RSK family of protein kinases.The Biochemical journal, 441 2
-
Golareh Habibi, S. Leung, Jennifer Law, K. Gelmon, H. Masoudi, D. Turbin, M. Pollak, T. Nielsen, D. Huntsman, S. Dunn (2008)
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypesBreast Cancer Research : BCR, 10
-
K. Shibao (1999)
10.1002/(SICI)1097-0215(19991210)83:6<732::AID-IJC6>3.0.CO;2-#Int. J. Cancer, 83
-
Yuanyuan Gao, A. Fotovati, Cathy Lee, Michelle Wang, G. Cote, E. Guns, B. Toyota, D. Faury, N. Jabado, S. Dunn (2009)
Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferaseMolecular Cancer Therapeutics, 8
-
A. Stratford, C. Fry, Curtis Desilets, A. Davies, Yong-Yeon Cho, Yvonne Li, Z. Dong, I. Berquin, Philippe Roux, S. Dunn (2008)
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cellsBreast Cancer Research : BCR, 10
-
R. Huschka, A. Barhoumi, Q. Liu, J. A. Roth, L. Ji (2012)
Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNAAm. Chem. Soc. Nano, 6
-
A. Hsieh, Yi Liu, Merritt Edlind, Nicholas Ingolia, M. Janes, A. Sher, Evan Shi, C. Stumpf, Carly Christensen, M. Bonham, Shunyou Wang, Pingda Ren, Michael Martin, Katti Jessen, M. Feldman, J. Weissman, K. Shokat, C. Rommel, D. Ruggero (2012)
The translational landscape of mTOR signalling steers cancer initiation and metastasisNature, 485
-
D. Hayes (2015)
Lessons for tumor biomarker trials: vicious cycles, scientific method & developing guidelinesExpert Review of Molecular Diagnostics, 15
-
Karen To, Yongjun Zhao, Helen Jiang, K. Hu, M. Wang, J. Wu, C. Lee, D. Yokom, A. Stratford, U. Klinge, P. Mertens, C. Chen, Marcel Bally, D. Yapp, Sandra Dunn (2007)
The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor ReceptorMolecular Pharmacology, 72
-
A. Stratford, S. Dunn (2011)
The promise and challenges of targeting RSK for the treatment of cancerExpert Opinion on Therapeutic Targets, 15
-
A. Fotovati, S. Abu-Ali, Pei-Shan Wang, L. Deleyrolle, Cathy Lee, J. Triscott, J. Chen, S. Franciosi, Yasuhiro Nakamura, Y. Sugita, T. Uchiumi, M. Kuwano, B. Leavitt, Sheila Singh, A. Jury, Chris Jones, H. Wakimoto, B. Reynolds, C. Pallen, S. Dunn (2011)
YB-1 bridges neural stem cells and brain tumor-initiating cells via its roles in differentiation and cell growth.Cancer research, 71 16
-
Y. Oda, Y. Ohishi, Tsuyoshi Saito, E. Hinoshita, T. Uchiumi, N. Kinukawa, Y. Iwamoto, K. Kohno, M. Kuwano, M. Tsuneyoshi (2003)
Nuclear expression of Y‐box‐binding protein‐1 correlates with P‐glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcomaThe Journal of Pathology, 199
-
K. Shibahara, K. Sugio, T. Osaki, T. Uchiumi, Y. Maehara, K. Kohno, K. Yasumoto, K. Sugimachi, M. Kuwano (2001)
Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 10
-
G. P. Gens, T. P. Stromskaya, O. V. Kalita, A. V. Vayman, E. Yu. Rybalkina (2009)
Examining protein YB-1 in breast cancerKlin. Lab. Diagn., 4
-
Huiling Shen, Wenlin Xu, Wenjuan Luo, Lei-lei Zhou, W. Yong, Fang Chen, Chao-qun Wu, Qiao-yun Chen, Xiao Han (2011)
Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma.Experimental hematology, 39 5
-
T. Fujii, N. Seki, Roka Namoto-Matsubayashi, Hiroki Takahashi, Y. Inoue, U. Toh, M. Kage, K. Shirouzu (2009)
YB-1 prevents apoptosis via the mTOR/STAT3 pathway in HER-2-overexpressing breast cancer cells.Future oncology, 5 2
-
M. Janz, N. Harbeck, P. Dettmar, U. Berger, A. Schmidt, K. Jürchott, M. Schmitt, H. Royer (2002)
Y‐box factor YB‐1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI‐1International Journal of Cancer, 97
-
K. Shibao, H. Takano, Y. Nakayama, K. Okazaki, N. Nagata, H. Izumi, T. Uchiumi, M. Kuwano, K. Kohno, H. Itoh (1999)
Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas.International journal of cancer, 83 6
-
I. Eliseeva, E. Kim, S. Guryanov, L. Ovchinnikov, D. Lyabin (2011)
Y-box-binding protein 1 (YB-1) and its functionsBiochemistry (Moscow), 76
-
Sarah Seton-Rogers (2012)
Therapeutics: siRNAs jump the hurdleNature Reviews Cancer, 12
-
J. Kalra, B. Sutherland, A. Stratford, W. Dragowska, K. Gelmon, S. Dedhar, Sandra Dunn, Sandra Dunn, Marcel Bally (2010)
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1Oncogene, 29
-
R. Bargou, K. Jürchott, C. Wagener, S. Bergmann, S. Metzner, K. Bommert, M. Mapara, K. Winzer, M. Dietel, B. Dörken, H. Royer (1997)
Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expressionNature Medicine, 3
-
(2010)
Intracellular protein YB 1 location and chemotherapy of breast cancer , Ross . Bioter -
Cathy Lee, Jaspreet Dhillon, Michelle Wang, Yuanyuan Gao, K. Hu, E. Park, A. Astanehe, M. Hung, P. Eirew, C. Eaves, S. Dunn (2008)
Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice.Cancer research, 68 21
-
(2013)
A link between intracellular YB 1 protein location in human multi drug resistance can cer cell culture -
(2014)
Problems of individual ized drug therapy in breast cancer patients -
D. Hanahan (2000)
10.1016/S0092-8674(00)81683-9Cell, 100
-
D. Hanahan, R. Weinberg (2011)
Hallmarks of Cancer: The Next GenerationCell, 144
- Publisher
- Springer Journals
- Copyright
- Copyright © Pleiades Publishing, Ltd. 2022
- ISSN
- 0006-2979
- eISSN
- 1608-3040
- DOI
- 10.1134/s0006297922140073
- Publisher site
- See Article on Publisher Site
Abstract
In the article, the author examines the properties of Y-box-binding protein (YB-1) and expression of the YBX-1 gene in various malignant tumors and provides the data from her own prospective study in breast cancer patients. YB-1 is a member of the highly conserved family of cold shock proteins with multiple functions in the cytoplasm and cell nucleus. YB-1 is involved in embryogenesis; it ensures cell proliferation and protects cell from the action of various aggressive environmental factors. In adult organisms, YB-1 is involved in a variety of cellular functions that regulate malignant phenotype in several types of tumors. YB-1 is a molecular marker of tumor progression that can be used in clinical practice as both prognostic factor and a target for anticancer therapy. Our prospective clinical study showed that expression of YB-1 mRNA is an independent prognostic factor, as breast cancer patients expressing YB-1 have a lower disease-free survival rate, regardless of the tumor stage and biological subtype. We recommend determining the level of YB-1 mRNA expression as a prognostic test in breast cancer patients.
Journal
Biochemistry (Moscow) – Springer Journals
Published: Jan 1, 2022
Keywords: YB-1; breast cancer; predictive test; the hallmarks of cancer